Blood Filter Start-Up ExThera Gets Fresenius Backing
This article was originally published in Clinica
Executive Summary
New investor Fresenius Medical Care Ventures GmbH is leading a Series B financing round in ExThera Medical to help fund clinical trials in Germany and the US of the latter’s Seraph Microbind affinity blood filter.